Q3 2020 13F Holders as of 9/30/2020
-
Type / Class
-
Equity / Common stock, $0.00001 par value per share
-
Shares outstanding
-
60.4M
-
Number of holders
-
189
-
Total 13F shares, excl. options
-
39.7M
-
Shares change
-
+2.6M
-
Total reported value, excl. options
-
$3.02B
-
Value change
-
+$219M
-
Put/Call ratio
-
0.66
-
Number of buys
-
108
-
Number of sells
-
-70
-
Price
-
$75.97
Significant Holders of Twist Bioscience Corp - Common stock, $0.00001 par value per share (TWST) as of Q3 2020
211 filings reported holding TWST - Twist Bioscience Corp - Common stock, $0.00001 par value per share as of Q3 2020.
Twist Bioscience Corp - Common stock, $0.00001 par value per share (TWST) has 189 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 39.7M shares
of 60.4M outstanding shares and own 65.74% of the company stock.
Largest 10 shareholders include ARK Investment Management LLC (3.16M shares), BlackRock Inc. (3.13M shares), JPMORGAN CHASE & CO (2.56M shares), VANGUARD GROUP INC (2.38M shares), Invesco Ltd. (1.94M shares), Sumitomo Mitsui Trust Holdings, Inc. (1.62M shares), Nikko Asset Management Americas, Inc. (1.62M shares), Capital World Investors (1.61M shares), STATE STREET CORP (1.44M shares), and FMR LLC (1.42M shares).
This table shows the top 189 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.